Free Trial

Inogen Q4 2023 Earnings Report

Inogen logo
$11.19 +0.72 (+6.88%)
As of 04:00 PM Eastern

Inogen EPS Results

Actual EPS
-$1.14
Consensus EPS
-$0.65
Beat/Miss
Missed by -$0.49
One Year Ago EPS
N/A

Inogen Revenue Results

Actual Revenue
$75.90 million
Expected Revenue
$78.09 million
Beat/Miss
Missed by -$2.19 million
YoY Revenue Growth
N/A

Inogen Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Inogen Earnings Headlines

Inogen reports preliminary Q4 revenue $79M, consensus $73.9M
A deadly mistake in my prediction…
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Inogen Expands U.S. Market with FDA Clearance
See More Inogen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inogen and other key companies, straight to your email.

About Inogen

Inogen (NASDAQ:INGN), a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

View Inogen Profile

More Earnings Resources from MarketBeat